← 返回

槐耳通过调节肿瘤微环境使胃癌细胞对 5-氟尿嘧啶敏感

英文原题:Trametes robiniophila Murr Sensitizes Gastric Cancer Cells to 5-Fluorouracil by Modulating Tumor Microenvironment.

查看英文原题

Trametes robiniophila Murr Sensitizes Gastric Cancer Cells to 5-Fluorouracil by Modulating Tumor Microenvironment.

PubMed 2022/05/17(内容时间) Front Pharmacol Q1 · IF 5.4(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

槐耳(Trametes robiniophila Murr,TRM)是一种传统中药,临床上用于增强免疫力和提高化疗疗效。

然而,TRM的作用机制尚不清楚。在前期研究中,我们发现槐耳正丁醇提取物(TRMBE)包含TRM的主要生物活性成分。在本研究中,我们旨在评估TRMBE与5-氟尿嘧啶(5-FU)联合治疗胃癌(GC)的效果,并探讨其作用机制。

研究发现,TRMBE显著增强了5-FU的抗癌活性,并延长了荷小鼠前胃癌(MFC)异种移植瘤小鼠的生存时间。我们观察到,TRMBE与5-FU联合使用降低了体内肝转移的风险。

此外,TRMBE与5-FU联合使用降低了外周血中免疫细胞因子IL-6、IL-10和TGF-β的水平,并提高了IFN-γ的水平。该联合治疗还显著降低了肿瘤微环境(TME)中多形核髓源性抑制细胞(PMN-MDSCs)和PD-1阳性CD8+ T细胞的水平,并增加了NK细胞的水平。

然而,在清除CD8+ T细胞和NK细胞后,TRMBE治疗无法在体内增强GC对5-FU的化疗敏感性。综上所述,我们的结果表明,TRMBE可通过调节PMN-MDSCs、CD8+ T细胞和NK细胞重塑GC的TME,从而改善5-FU的治疗效果。

本研究提示,TRMBE与5-FU联合使用可增强免疫力,可能成为GC治疗的一种有前景的方法。

展开英文摘要原文

Trametes robiniophila Murr (TRM) is a traditional Chinese medicine which has been used in clinics for enhancing immunity and improving the efficacy of chemotherapy.

However, the mechanisms of action of TRM are unknown. In the previous study, we found that the Trametes robiniophila Murr n-butanol extract (TRMBE) comprises the major bioactive components of TRM. In the present study, we aimed to assess the combinational effects of TRMBE and 5-fluorouracil (5-FU) on the treatment of gastric cancer (GC) and explore its mechanism of action. It was found that TRMBE significantly potentiated the anticancer activity of 5-FU and prolonged the survival time of mice bearing Mouse Forestomach Carcinoma (MFC) xenograft tumors.

We observed that the combination of TRMBE and 5-FU decreased the risk of liver metastasis in vivo .

Furthermore, the combination of TRMBE and 5-FU reduced the levels of immune cytokines IL-6, IL-10, and TGF-β and increased the level of IFN-γ in peripheral blood. This combination therapy also significantly decreased the levels of polymorphonuclear myeloid-derived suppressor cells (PMN-MDSCs) and PD-1-positive CD8 + T cells and increased the levels of NK cells in tumor microenvironment (TME).

However, TRMBE treatment was unable to enhance the chemosensitivity of GC to 5-FU in vivo after the depletion of CD8 + T and NK cells. Taken together, our results demonstrate that TRMBE can reshape the TME of GC by regulating PMN-MDSCs, CD8 + T cells, and NK cells, therefore improving the therapeutic effects of 5-FU.

This study suggests that the combination of TRMBE and 5-FU could enhance immunity and could be a promising approach for GC treatment.

论文信息

作者
Xu JL、Yuan L、Hu C、Weng CY、Xu HD、Shi YF、Huang L、Ying JE
第一作者单位
The First Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou, China.China
通讯作者单位
The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, China.China
期刊
Frontiers in pharmacology2022
原文标识
PubMed 35656301 · DOI 10.3389/fphar.2022.911663